Lupin launches generic seizure drug in US
The company has launched Clobazam tablets in the strengths of 10 mg and 20 mg, after having received an approval from the United…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Granules India’s total income for FY’19 up by 35 per cent
The company’s consolidated total income for the fourth quarter of FY’19 was Rs 615 crores -- an increase of 20 per cent from the…
Cadila announced a four-day holiday for its employees in May
The four day vacation has been termed as ‘Happy Shift’ by the company authorities
Netmeds to set up 26 ‘Fulfillment Centers’ across India by 2020
The online delivery firm will establish centres in Tier II cities to facilitate quick & efficient, last-mile delivery of…
Glenmark clears phase 3 study on rhinitis treatment
The company had been studying Ryaltris, a nasal spray, for the treatment of seasonal allergic rhinitis
Lupin to sell Aptissen products in Canada
Lupin has been granted immediate distribution rights in Canada for Synolis VA, an injection used for the treatment of…
Research Point Global and WuXi CDS to rebrand as WuXi Clinical
The newly combined CRO specializes in collaborative partnering for global clinical trials
Indoco’s new solid dosages facility at Baddi receives UK-MHRA approval
The plant, which was established in 2016, had its first ever regulatory inspection in October, 2018
Natco Pharma’s marketing partner gets USFDA approval for chest pain tablets
The company's marketing partner, Alvogen, received ANDA approval from USFDA for Nitroglycerin Sublingual Tablets USP, 0.3 mg, 0.4…
Biocon, partnering with Mylan, to share profits in global commercialisation of Hulio
The pharma major had earlier retained economic interest in the European sales of Hulio, (biosimilar Adalimumab), which is…
Alembic partners with SPH Group and Adia for Chinese market
The JV will commercialise products in the Chinese market which has an increasing demand for generic drugs
Lupin receives tentative USFDA approval for Fosaprepitant for Injection
The company can now market a generic version of Merck's Emend for Injection, 150 mg Single-Dose Vial
Yasir Rawjee appointed as CEO of Glenmark Life Sciences
Rawjee, who will now head the company's newly created API unit, was previously Head of Global API Operations at Mylan Inc
Hester Biosciences recommends a final dividend of INR 7 per share
The company declared its consolidated financial report, registering a 44 per cent hike in profit margins for FY19
Unichem Labs gets USFDA tentative nod for allergic rhinitis drug
The company got the US health regulator's nod for its Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride extended-release…
Merck Limited renamed as Procter & Gamble Health Limited
New name reflects new identity of the listed entity as part of the P&G Group
Vivimed recalls hypertensive drug from US market due to impurities
According to the USFDA, the drug, Losartan Potassium Tablet, could put certain patients under a heightened risk of developing…
Morepen Labs’ Q4 net profit up by 54 per cent at Rs 10.49 crore
The company declared that with the latest surge in profits, it has now officially become debt free
Medlife acquires medicine delivery startup Myra Medicines
While Myra was earlier handling about 4,000 deliveries a day in Bengaluru, its services are now ready to be scaled across 22…
Dr. Reddy’s Lab launches Testosterone Gel, 1.62% in the US
The drug company has received USFDA's approval to sell Testosterone Gel, 1.62%, which is a generic version of AndroGel